◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › X › XRN

Chiron Real Estate Inc. (XRN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · DATA UPDATED 2026-10-02

Chiron Real Estate Inc. (XRN) operates in the REIT - HEALTHCARE FACILITIES industry and is headquartered in Bethesda, United States with about 30 employees. Its market capitalization is roughly $440 million. In the fiscal year ended 2025-12-31, XRN reported $161M in revenue and ($6M) in net income.

Chiron is a real estate investment trust focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Chiron Real Estate Inc. was established in 2011 and was incorporated in Maryland.

Interactive charts & full statements → Open the XRN valuation workbench →

XRN Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Total Revenue	$157M	$161M	$138M	$141M	$137M	$116M	$94M	$71M	$53M	$30M	$8M	$2M	$0M	—	—
Gross Profit	$0M	$10M	$109M	$113M	$112M	$100M	$83M	$64M	$49M	$28M	$7M	$1M	$0M	—	—
Gross Margin %	0.0%	6.4%	78.9%	80.1%	81.6%	86.6%	88.4%	90.8%	93.0%	93.8%	82.2%	50.5%	5.4%	—	—
Operating Income (EBIT)	$39M	$49M	$33M	$38M	$39M	$37M	—	$50M	$22M	$7M	($2M)	($2M)	($1M)	$0M	$0M
Operating Margin %	24.8%	30.7%	23.6%	26.9%	28.2%	31.9%	—	70.6%	41.8%	24.3%	-27.4%	-74.0%	-171.4%	—	—
Net Income	$57M	($6M)	$7M	$21M	$19M	$18M	($2M)	$9M	$13M	$0M	($6M)	($2M)	($1M)	$0M	$0M
Net Margin %	36.3%	-3.6%	4.8%	14.6%	14.0%	15.2%	-2.1%	13.1%	25.4%	-0.1%	-78.6%	-78.1%	-171.4%	—	—
EBITDA	$158M	$97M	$91M	$112M	$103M	$85M	$53M	$51M	$40M	$17M	$2M	$1M	$0M	$0M	—
Earnings Per Share (EPS)	$4.39	$-0.44	$2.51	$7.86	$7.31	$7.27	$-1.04	$6.82	$15.35	$-0.05	$-17.08	$-160.92	$-337.23	$-57.90	$-62.63
Shares Outstanding (M)	13M	13M	3M	3M	3M	2M	2M	1M	1M	1M	0M	0M	0M	0M	0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$40M	$38M	$38M	$41M	$41M	$38M	$35M	$34M
Gross Profit	($1M)	($1M)	$0M	$2M	$2M	$3M	$28M	$27M
Gross Margin %	-2.1%	-2.2%	-0.1%	5.7%	6.0%	7.0%	79.4%	78.2%
Operating Income (EBIT)	$9M	$9M	$9M	$12M	$12M	$13M	$6M	$9M
Operating Margin %	23.2%	23.4%	24.4%	30.7%	28.4%	33.9%	18.3%	25.5%
Net Income	$66M	$2M	($6M)	($5M)	$1M	$4M	$3M	$3M
Net Margin %	166.7%	4.5%	-14.3%	-11.2%	1.6%	9.4%	8.1%	9.5%
EBITDA	$96M	$24M	$17M	$21M	$27M	$28M	$24M	$24M
Earnings Per Share (EPS)	$5.01	$0.13	$-0.41	$-0.34	$0.08	$0.27	$1.06	$1.23
Shares Outstanding (M)	13M	13M	13M	13M	13M	13M	3M	3M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRN Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Cash from Operations (CFO)	$76M	$74M	$70M	$68M	$77M	$69M	$35M	$36M	$25M	$12M	($3M)	$0M	$0M	$0M	$0M
Capital Expenditures (CapEx)	$262M	$82M	$95M	$10M	$156M	$202M	$219M	$257M	$181M	$252M	$150M	$32M	$22M	$0M	$0M
Free Cash Flow (FCF)	($188M)	($8M)	($25M)	$58M	($80M)	($133M)	($184M)	($220M)	($156M)	($241M)	($153M)	($32M)	($22M)	$0M	$0M
FCF Margin %	-119.8%	-5.0%	-18.1%	41.4%	-58.1%	-114.6%	-197.0%	-311.6%	-293.3%	-796.1%	-1895.9%	-1572.2%	-5786.8%	—	—
Dividends Paid	$48M	$58M	$66M	$65M	$64M	$58M	$46M	$35M	$25M	$16M	$4M	$0M	$0M	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$23M	$13M	$22M	$18M	$22M	$12M	$21M	$16M
Capital Expenditures (CapEx)	$254M	$2M	$3M	$3M	$40M	$35M	$54M	$5M
Free Cash Flow (FCF)	($231M)	$11M	$18M	$14M	($18M)	($22M)	($33M)	$11M
FCF Margin %	-582.2%	29.4%	47.6%	35.2%	-44.4%	-58.9%	-95.4%	32.5%
Dividends Paid	$11M	$13M	$12M	$12M	$17M	$17M	$17M	$16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRN Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31
Total Assets	$1.4B	$1.2B	$1.3B	$1.3B	$1.4B	$1.3B	$1.1B	$885M	$636M	$475M	$227M	$65M	$25M	$0M	$0M	$0M
Cash & Cash Equivalents	$11M	$12M	$7M	$1M	$4M	$7M	$6M	$3M	$4M	$5M	$20M	$9M	$0M	$0M	$0M	$0M
Total Liabilities	$688M	$712M	$701M	$662M	$744M	$626M	$643M	$425M	$336M	$216M	$72M	$65M	$23M	$0M	$0M	$0M
Total Debt (Short + Long-Term)	$634M	$1M	$646M	$611M	$694M	$572M	$18M	$6M	$276M	$0M	$28M	$0M	$0M	$0M	$0M	$0M
Total Shareholders' Equity	$657M	$510M	$534M	$584M	$633M	$623M	$445M	$430M	$269M	$246M	$155M	$0M	$2M	$0M	$0M	$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XRN viewer.

Other Companies in REIT - HEALTHCARE FACILITIES

NHI · National Health Investors Inc — $3 billion
LTC · LTC Properties Inc — $2 billion
MPT · Medical Properties Trust, Inc. — $1 billion
UHT · Universal Health Realty Income Trust — $530 million
CHCT · Community Healthcare Trust Inc — $373 million
OHI · Omega Healthcare Investors Inc — $15 billion
AHR · American Healthcare REIT, Inc. — $12 billion
CTRE · CareTrust REIT Inc. — $9 billion

← XRMI All “X” companies XRP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.